Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 183 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 932. Clear
Clear
Q2
SMITHBUCKLIN CORPORATION for ASTCT
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $70,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid
View → Q2
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues
View → Q2
BRACEWELL LLP for AQUESTIVE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · Indiana · House · Senate · $60,000.00 income
Consumer Issues/Safety/Products, Health Issues
View → Q2
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Defense, Medicare/Medicaid, Health Issues
View → Q2
NATIONWIDE CHILDREN'S HOSPITAL, INC. for NATIONWIDE CHILDREN'S HOSPITAL INC
2nd Quarter (Apr 1 - June 30) 2026 · Ohio · House · Senate
Health Issues, Medicare/Medicaid
View → Q2
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate
Health Issues
View → Q2
CURE SMA for CURE SMA
2nd Quarter (Apr 1 - June 30) 2026 · Illinois · House · Senate
Health Issues, Defense, Housing, Medical/Disease Research/Clinical Labs
View → Q2
LIFE SCIENCES PENNSYLVANIA for LIFE SCIENCES PENNSYLVANIA
2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate
Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View → Q2
LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $50,000.00 income
Health Issues
View → Q2
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $30,000.00 income
Health Issues
View → Q1
NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES for NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Education, Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid
View → Q1
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Defense
View → Q1
YC CONSULTING, LLC for PATIENTS RISING NOW
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues
View → Q1
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q1
NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES for NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Taxation/Internal Revenue Code, Health Issues, Education, Medicare/Medicaid
View → Q1
EPILEPSY FOUNDATION for EPILEPSY FOUNDATION
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate
Education, Budget/Appropriations, Health Issues, Civil Rights/Civil Liberties
View → Q1
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $80,000.00 income
Pharmacy, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View → Q1
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Tariff (miscellaneous tariff bills), Agriculture, Taxation/Internal Revenue Code
View → Q1
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate
Health Issues
View → Q1
VANDERBILT UNIVERSITY MEDICAL CENTER for VANDERBILT UNIVERSITY MEDICAL CENTER
1st Quarter (Jan 1 - Mar 31) 2026 · Tennessee · House · Senate
Pharmacy, Immigration, Budget/Appropriations, Health Issues
View → Q1
THE MCMANUS GROUP for FULCRUM THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income
Health Issues
View → Q1
SMITHBUCKLIN CORPORATION for ASTCT
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $70,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid
View → Q1
NATIONWIDE CHILDREN'S HOSPITAL, INC. for NATIONWIDE CHILDREN'S HOSPITAL INC
1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate
Health Issues, Medicare/Medicaid
View → Q1
LIFE SCIENCES PENNSYLVANIA for LIFE SCIENCES PENNSYLVANIA
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate
Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View → Q1
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security
View →
Page 1 of 8 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem